Select Language:
EnglishEspañol
Adjust Text Size:
change font sizechange font sizechange font sizechange font sizechange font sizechange font size

Browse Clinical Trials


Join the Email List

Sign up for our email bulletin

Go

Participant Stories

“I feel like there is hope, great hope, more hope now than ever before.” –Peggy Willocks, Diagnosed 14 years

Read More

Recently Diagnosed with Parkinson's Disease?

If you have recently been diagnosed with Parkinson’s disease (PD) understanding the disease, and learning about the resources available to you, are good first steps.

Learn More

Drug to Slow Parkinson's Disease Progression

Official Study Title: Use of Angiotensin II Blockade to Delay Parkinson's Disease
Sponsor: GenoMed, Inc.
Clinicaltrials.gov ID:
Study ID:

Summary

This study tests a new drug treatment that may slow the progression of Parkinson's disease.  Parkinson's DiseaseA chronic, slowly progressive disease of the nervous system characterized by the combination of tremor, rigidity, bradykinesia and stooped posture, among other symptoms.

Parkinson's disease is caused by the death of certain brain cells involved in movement control. Though the cause of this cell death is unknown, it is thought that certain chemicals found naturally in the blood may be the cause. By blocking the production of these chemicals, it may be possible to slow the progression of Parkinson's disease.

The participant's personal doctor will prescribe the drug. If after taking the drug for 2-3 months participants are doing well, they may continue taking it indefinitely.

Study Phase

Not Specified
What is a study phase?

Symptoms Addressed: Movement Symptoms

Tremor,  TremorShaking or rhythmic movement, especially in the hands but in other parts of the body. Often occurs when at rest, such as in the RESTING TREMOR. Slowness of movement (bradykinesia)  BradykinesiaSlowness of movement. , Rigidity,  RigidityA symptom in which muscles feel stiff and display resistance to movement even when another person tries to move the affected part of the body. Balance

Time Commitment

  • Contact trial organizers
  • Monthly email follow-up with study staff

Eligibility

  • Gender(s) Accepted: Either

Inclusion Criteria

  • Anyone with Parkinson's disease may be eligible

Enrollment

Date Enrollment Began: Dec 01 2003
Last Updated Date: Jan 04 2005
Trial Post Date: Jan 04 2005
Website:

Primary Contacts and Locations

All States


built@zoomedia